Jacobi Capital Management’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-16,500
| Closed | -$489K | – | 494 |
|
|
2023
Q4 | $489K | Hold |
16,500
| – | – | 0.05% | 292 |
|
|
2023
Q3 | $262K | Sell |
16,500
-10,000
| -38% | -$166K | 0.03% | 379 |
|
|
2023
Q2 | $500K | Sell |
26,500
-19,500
| -42% | -$230K | 0.06% | 275 |
|
|
2023
Q1 | $177K | Hold |
46,000
| – | – | 0.02% | 412 |
|
|
2022
Q4 | $228K | Sell |
46,000
-1,500
| -3% | -$8.13K | 0.03% | 385 |
|
|
2022
Q3 | $227K | Hold |
47,500
| – | – | 0.03% | 371 |
|
|
2022
Q2 | $214K | Buy |
47,500
+5,000
| +12% | +$21.7K | 0.03% | 383 |
|
|
2022
Q1 | $202K | Buy |
42,500
+10,000
| +31% | +$55.4K | 0.02% | 406 |
|
|
2021
Q4 | $241K | Hold |
32,500
| – | – | 0.03% | 386 |
|
|
2021
Q3 | $184K | Buy |
32,500
+2,900
| +10% | +$16.8K | 0.02% | 412 |
|
|
2021
Q2 | $195K | Buy |
29,600
+2,100
| +8% | +$14.6K | 0.03% | 381 |
|
|
2021
Q1 | $223K | Hold |
27,500
| – | – | 0.03% | 327 |
|
|
2020
Q4 | $177K | Buy |
27,500
+15,000
| +120% | +$87.5K | 0.03% | 335 |
|
|
2020
Q3 | $45K | Hold |
12,500
| – | – | 0.01% | 520 |
|
|
2020
Q2 | $58K | Hold |
12,500
| – | – | 0.01% | 448 |
|
|
2020
Q1 | $43K | Hold |
12,500
| – | – | 0.01% | 452 |
|
|
2019
Q4 | $64K | Hold |
12,500
| – | – | 0.01% | 426 |
|
|
2019
Q3 | $30K | Hold |
12,500
| – | – | 0.01% | 539 |
|
|
2019
Q2 | $27K | Hold |
12,500
| – | – | 0.01% | 551 |
|
|
2019
Q1 | $34K | Hold |
12,500
| – | – | 0.01% | 477 |
|
|
2018
Q4 | $60K | Hold |
12,500
| – | – | 0.02% | 359 |
|
|
2018
Q3 | $118K | Hold |
12,500
| – | – | 0.03% | 300 |
|
|
2018
Q2 | $122K | Hold |
12,500
| – | – | 0.04% | 286 |
|
|
2018
Q1 | $127K | Sell |
12,500
-2,500
| -17% | -$24.7K | 0.04% | 259 |
|
|
2017
Q4 | $101K | Hold |
15,000
| – | – | 0.03% | 259 |
|
|
2017
Q3 | $100K | Hold |
15,000
| – | – | 0.03% | 242 |
|
|
2017
Q2 | $110K | Hold |
15,000
| – | – | 0.04% | 187 |
|
|
2017
Q1 | $51K | Hold |
15,000
| – | – | 0.03% | 239 |
|
|
2016
Q4 | $36K | Buy |
+15,000
| New | +$30.1K | 0.02% | 258 |
|
|
2016
Q3 | – | Sell |
-64
| Closed | – | – | 753 |
|
|
2016
Q2 | $0 | Buy |
+64
| New | +$401 | ﹤0.01% | 726 |
|
Other funds holding IMGN
Jacobi Capital Management's IMGN Position: Q1 2024 in Review
Jacobi Capital Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 16,500 shares — an estimated $489K sold.
Jacobi Capital Management first reported a position in IMGN in Q2 2016 and held it in 30 quarters. The position peaked at $500K in Q2 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.
- Jacobi Capital Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
- Jacobi Capital Management sold 16,500 Immunogen Inc shares in Q1 2024, an estimated $489K.
- Jacobi Capital Management first reported a position in Immunogen Inc in Q2 2016 and held it in 30 quarters.
- Jacobi Capital Management's Immunogen Inc position peaked at $500K in Q2 2023.
- 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.
Based on Jacobi Capital Management's 13F filing for Q1 2024, filed 10 May 2024.